These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 5880731)

  • 1. [Experience with the use of heparin in ambular prevention of coronary thrombosis under ambulatory conditions].
    Aleĭnikova LI
    Kardiologiia; 1965; 5(4):50-2. PubMed ID: 5880731
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: Prevention of coronary-artery thrombosis by heparin prophylaxis.
    Sharnoff JG
    Lancet; 1973 Dec; 2(7841):1321. PubMed ID: 4127659
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of experimental thrombosis of the coronary artery, in anesthetized dogs, with a low molecular weight heparin, enoxaparine (PK 10169)].
    Uzan A; Clairefond P; Mardiguian J; Trillou M; Le Fur G; Mestre M
    Ann Pharm Fr; 1985; 43(6):539-46. PubMed ID: 3838029
    [No Abstract]   [Full Text] [Related]  

  • 4. Anticoagulation in coronary heart disease: heparin and warfarin trials.
    Lopez LM; Mehta JL
    Cardiovasc Clin; 1987; 18(1):215-29. PubMed ID: 2955891
    [No Abstract]   [Full Text] [Related]  

  • 5. [Heparin in the pathogenesis, prevention and therapy of ischemic heart disease].
    Riecanský I; Kusá O; Luknárová O; Haviar V
    Vnitr Lek; 1983 May; 29(5):439-45. PubMed ID: 6880060
    [No Abstract]   [Full Text] [Related]  

  • 6. Left ventricular thrombosis and stroke following myocardial infarction.
    Lancet; 1990 Mar; 335(8692):759-60. PubMed ID: 1969513
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes of the thrombagglutination test in coronary disease after treatment with heparin].
    Atanasov K; Iovkova T
    Kardiologiia; 1977 May; 17(5):142-3. PubMed ID: 886741
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction.
    Turpie AG; Robinson JG; Doyle DJ; Mulji AS; Mishkel GJ; Sealey BJ; Cairns JA; Skingley L; Hirsh J; Gent M
    N Engl J Med; 1989 Feb; 320(6):352-7. PubMed ID: 2643772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental coronary artery spasm-induced thrombosis and myocardial infarction prevented by intravenous nifedipine. A study of hemodynamics, electrocardiograms, biochemistry and pathology.
    Jiang YQ; Na S; Ma FX; Shi HQ
    Chin Med J (Engl); 1988 Oct; 101(10):761-7. PubMed ID: 3150711
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experience in preventive therapy of patients with chronic coronary insufficiency under polyclinic conditions].
    Paranskaia ZhA
    Klin Med (Mosk); 1970 Apr; 48(4):109-12. PubMed ID: 5425704
    [No Abstract]   [Full Text] [Related]  

  • 11. A novel synthetic inhibitor of factor Xa decreases early reocclusion and improves 24-h patency after coronary fibrinolysis in dogs.
    Abendschein DR; Baum PK; Verhallen P; Eisenberg PR; Sullivan ME; Light DR
    J Pharmacol Exp Ther; 2001 Feb; 296(2):567-72. PubMed ID: 11160645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin and atherosclerosis.
    Engelberg H
    Monogr Atheroscler; 1978; (8):1-69. PubMed ID: 360049
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. Helvetica Investigators.
    Serruys PW; Herrman JP; Simon R; Rutsch W; Bode C; Laarman GJ; van Dijk R; van den Bos AA; Umans VA; Fox KA
    N Engl J Med; 1995 Sep; 333(12):757-63. PubMed ID: 7643882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute left main occlusion during percutaneous coronary intervention associated with heparin induced thrombocytopenia with thrombosis syndrome.
    Ziakas A; Gavrilidis S; Makris P; Louridas G
    J Interv Cardiol; 2005 Apr; 18(2):139-44. PubMed ID: 15882162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prophylactic treatment of patients with chronic coronary insufficiency under ambulatory conditions].
    Dolbilova VA
    Kardiologiia; 1967 Sep; 7(9):39-42. PubMed ID: 4181201
    [No Abstract]   [Full Text] [Related]  

  • 16. Registry of prospective clinical trials--fifth report.
    Verstraete M
    Thromb Haemost; 1982 Dec; 48(3):334-8. PubMed ID: 6761891
    [No Abstract]   [Full Text] [Related]  

  • 17. Heparin in coronary artery disease: new uses for an old drug.
    Violaris AG; Angelini GD
    Br J Hosp Med; 1993 Jan 6-19; 49(1):37-9, 42-3. PubMed ID: 8347182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experience with discontinuous heparin in coronary insufficiency].
    SAN-CRISTOBAL D; SEPULVEDA G
    Rev Med Chil; 1953 Nov; 81(11):662-5. PubMed ID: 13156131
    [No Abstract]   [Full Text] [Related]  

  • 19. The clinical use of heparin.
    Engelberg H
    Curr Ther Res Clin Exp; 1975 Jul; 18(1 Pt1):34-44. PubMed ID: 808389
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative study of cardiac and vascular implants in relation to thrombosis.
    Hufnagel CA; Conrad PW; Gillespie JF; Pifarre R; Ilano A; Yokoyama T
    Surgery; 1967 Jan; 61(1):11-6. PubMed ID: 6016658
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.